ResearcherShanghai Jiao Tong UniversityNo recent work listed
Peng Xue
Known by name at one institution; no external author ID yet. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2014: 2 papers · 2015: none · 2016: 1 paper · 2017: 2 papers
Papers 5
- Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients. First author DOI 10.1038/s41598-017-03153-6↗
- Validation of Lymphocyte-to-Monocyte Ratio as a Prognostic Factor in Advanced Pancreatic Cancer: An East Asian Cohort Study of 2 Countries. Co-author DOI 10.1097/mpa.0000000000000891↗
- Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy. Co-author DOI 10.1007/s10147-015-0864-x↗
- Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients. Co-author DOI 10.1002/cam4.204↗
- Comparative outcomes between initially unresectable and recurrent cases of advanced pancreatic cancer following palliative chemotherapy. Co-author DOI 10.1097/mpa.0000000000000050↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Masashi Kanai · 4 shared papers, 2014–2017 · strength 0.19
- Paper Validation of Lymphocyte-to-Monocyte Ratio as a Prognostic Factor in Advanced Pancreatic Cancer: An East Asian Cohort S… DOI 10.1097/mpa.0000000000000891↗
- Paper Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic canc… DOI 10.1007/s10147-015-0864-x↗
- Paper Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients. DOI 10.1002/cam4.204↗
- Kyoichi Takaori · 4 shared papers, 2014–2017 · strength 0.19
- Paper Validation of Lymphocyte-to-Monocyte Ratio as a Prognostic Factor in Advanced Pancreatic Cancer: An East Asian Cohort S… DOI 10.1097/mpa.0000000000000891↗
- Paper Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic canc… DOI 10.1007/s10147-015-0864-x↗
- Paper Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients. DOI 10.1002/cam4.204↗
- Weiyi Huang · 2 shared papers, 2017 · strength 0.13
- Paper Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients. DOI 10.1038/s41598-017-03153-6↗
- Paper Validation of Lymphocyte-to-Monocyte Ratio as a Prognostic Factor in Advanced Pancreatic Cancer: An East Asian Cohort S… DOI 10.1097/mpa.0000000000000891↗
- Junjie Hang · 2 shared papers, 2017 · strength 0.13
- Paper Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients. DOI 10.1038/s41598-017-03153-6↗
- Paper Validation of Lymphocyte-to-Monocyte Ratio as a Prognostic Factor in Advanced Pancreatic Cancer: An East Asian Cohort S… DOI 10.1097/mpa.0000000000000891↗
- Tsutomu Chiba · 3 shared papers, 2014–2016 · strength 0.12
- Paper Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic canc… DOI 10.1007/s10147-015-0864-x↗
- Paper Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients. DOI 10.1002/cam4.204↗
- Paper Comparative outcomes between initially unresectable and recurrent cases of advanced pancreatic cancer following palliat… DOI 10.1097/mpa.0000000000000050↗
- Shinji Üemoto · 3 shared papers, 2014–2016 · strength 0.12
- Paper Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic canc… DOI 10.1007/s10147-015-0864-x↗
- Paper Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients. DOI 10.1002/cam4.204↗
- Paper Comparative outcomes between initially unresectable and recurrent cases of advanced pancreatic cancer following palliat… DOI 10.1097/mpa.0000000000000050↗
- Yuzo Kodama · 3 shared papers, 2014–2016 · strength 0.12
- Paper Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic canc… DOI 10.1007/s10147-015-0864-x↗
- Paper Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients. DOI 10.1002/cam4.204↗
- Paper Comparative outcomes between initially unresectable and recurrent cases of advanced pancreatic cancer following palliat… DOI 10.1097/mpa.0000000000000050↗
- Haiyan Yang · 1 shared paper, 2017 · strength 0.07
- Yuzo Kodama · 1 shared paper, 2017 · strength 0.07
- Ning Li · 1 shared paper, 2017 · strength 0.07
- Liwei Wang · 1 shared paper, 2017 · strength 0.07
- Tadayuki Kou · 1 shared paper, 2016 · strength 0.04
- Manabu Muto · 1 shared paper, 2016 · strength 0.04
- Toshihiko Masui · 1 shared paper, 2016 · strength 0.04
- Shujiro Yazumi · 1 shared paper, 2016 · strength 0.04
- Akira Kurita · 1 shared paper, 2016 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.